Oncology Nurse Edition
ONCOLOGY Nurse Edition®
ONCOLOGY Nurse Edition Vol 23 No 4
Volume: 23
Issue: 4
ONCOLOGY Nurse Edition Vol 23 No 2
Volume: 23
Issue: 2
ONCOLOGY Nurse Edition Vol 22 No 8
Volume: 22
Issue: 8
ONCOLOGY Nurse Edition Vol 22 No 4
Volume: 22
Issue: 4
ONCOLOGY Nurse Edition Vol 22 No 2
Volume: 22
Issue: 2
ONCOLOGY Nurse Edition Vol 25 No 10
Volume: 25
Issue: 10
ONCOLOGY Nurse Edition Vol 25 No 4
Volume: 25
Issue: 4
ONCOLOGY Nurse Edition Vol 25 No 2
Volume: 25
Issue: 2
ONCOLOGY Nurse Edition Vol 26 No 8
Volume: 26
Issue: 8
ONCOLOGY Nurse Edition Vol 26 No 5
Volume: 26
Issue: 5
ONCOLOGY Nurse Edition Vol 24 No 4
Volume: 24
Issue: 4
ONCOLOGY Nurse Edition Vol 25 No 7
Volume: 25
Issue: 7
ONCOLOGY Nurse Edition Vol 22 No 11
Volume: 22
Issue: 11
ONCOLOGY Nurse Edition Vol 24 No 2
Volume: 24
Issue: 2
ONCOLOGY Nurse Edition Vol 24 No 10
Volume: 24
Issue: 10
ONCOLOGY Nurse Edition Vol 24 No 7
Volume: 24
Issue: 7
ONCOLOGY Nurse Edition Vol 23 No 11
Volume: 23
Issue: 11
ONCOLOGY Nurse Edition Vol 23 No 8
Volume: 23
Issue: 8
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
3
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
4
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
5
